2024 - Landmark Trial of Lenacapavir: A Breakthrough in HIV Prevention for African Women
In a groundbreaking 2024 trial, the antiviral drug lenacapavir achieved 100% HIV prevention among African women participants, marking a significant step forward in global health and women's empowerment in controlling their health outcomes.